International Biotechnology Trust plc - IBT

Investing in biotechnology for a healthier future

Access the fast-growing biotechnology sector through an actively managed, diversified investment trust

Targeting high growth, International Biotechnology Trust plc (IBT) backs innovative companies addressing high unmet medical needs and offers investors the opportunity for financial returns.

Behind the trust - read our philosophy article >

Seeking the best in biotech

International Biotechnology Trust invests in around 100 of the most innovative, high quality quoted and unquoted companies across the entire spectrum of the biotech and other life sciences sectors.

A keen focus on risk management

An acute understanding of valuation and the biotechnology investment cycle informs the managers’ top down overlay and they take prudent steps to reduce individual company risk ahead of binary events. This has contributed to their outperformance against the index and their peers.

Income generating

A dividend of 4% of closing net asset value, paid biannually, offers investors a highly differentiated and reliable source of income.

Portfolio Company Updates

Merck to acquir Terns Pharmaceuticals - March 2026
Read
Servier to acquire Day One - March 2026
Read
Novartis to acquire Avidity Biosciences - October 2025
Read
Novo Nordisk to acquire Akero - October 2025
Read
Genmab to acquire Merus - September 2025
Read
Pfizer agrees to acquire Metsera - September 2025
Read
Acquisition of 89Bio by Roche - September 2025
Read
Merck to acquire Verona Pharma - July 2025
Read
Sanofi to acquire Blueprint Medicines - June 2025
Read
Merck to acquire SpringWorks - April 2025
Read
Acquisition of Intra-Cellular Therapies by Johnson & Johnson - January 2025
Read

Download Key Material

IBT Outlook 2026
Annual Report and Accounts 2025
Half Year Report & Accounts 2025
Factsheet
Download
Kepler Research
Download
Key Information Document
Download

Portfolio & Performance Hub

Schroder ISF GTR MStar Rating 5 stars

Source: Morningstar, February 2026

Association of Investment Companies ISA Millionaire Logo for 2026. An investment in this trust since 1995, using your full ISA allowance every year, would now result in you having over one million pounds thanks to the long terms growth potential and powerful compounding of these vehicle

Source: Association of Investment Companies, 2026

Citywire's investment trust manager ratings are three-year risk-adjusted measures of the movement in a trust’s net asset value (NAV). They are based on the ‘information ratio’, which is a measure of a fund manager’s skill against a benchmark. The benchmarks are applied at the trust level, using month-end cum fair NAV. This methodology is consistent with our annual Citywire Investment Trust Awards and our established fund manager ratings. For a fund manager to be considered, they need a 36-month track record. Each trust they manage also requires a 36-month track record, unless it aligns with a trust in the same sector and is assigned the same benchmark as an eligible trust.

Source: Citywire, 2026

Income 2026 badge

Source: Kepler Trust Intelligence, 2026

In the Media

Kepler: Ideas for your ISA
Watch >
Kepler: Fund Analysis
Read
Trustnet: Making hay in the sunshine as biotech’s outlook brightens
Read
Interactive Investor: Investment trust winners and losers in 2025
Read >
Trustnet: The best funds and trusts in November 2025
Read
Kepler: Results Analysis
Read
Trustnet: Chequebooks at the ready: Biotech is on the shopping list
Read
This is Money: The biotech fund backing companies that could change how we live
Read
Citywire: IBT moved to AA rating for the first time
Read
Citywire: IBT feature on healthcare trust picks
Read
Kepler Market Matters Podcast: IBT's Ailsa Craig
Listen
Kepler: Talking Trusts - Interview with Ailsa Craig and Marek Poszepczynski
Listen
Investment Week: Biotech innovation will overcome policy noise
Read
Trustnet: The sector-specific trusts consistently outperforming for Sharpe ratio
Read
Kepler: Half Year Results Analysis
Read

Investment Manager's Blog

View all insights

Documents

Document Archive
View
AGM Results 2025
Download
Change of Auditors
Read
AIFM Disclosure Statement
Download
Terms of Reference: Management Engagement Committee
Download
Terms of Reference: Nomination Committee
Download
Terms of Reference: Audit Committee
Download

Invest in the International Biotechnology Trust plc (IBT)

It is easy to make regular, tax-efficient investments into investment trust shares with a UK online stockbroker. We recommend you seek financial advice from an independent adviser before making an investment decision.

    Visit website